Get the Stockscreener App
0.3659
0.65%
-0.0024
After Hours:
.36
-0.0059
-1.61%
Aethlon Medical Inc stock is traded at $0.3659, with a volume of 102.56K.
It is down -0.65% in the last 24 hours and down -29.32% over the past month.
Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.
See More
Previous Close:
$0.3683
Open:
$0.351
24h Volume:
102.56K
Relative Volume:
0.10
Market Cap:
$7.56M
Revenue:
$294.20K
Net Income/Loss:
$-12.25M
P/E Ratio:
-0.0725
EPS:
-5.05
Net Cash Flow:
$-10.77M
1W Performance:
-8.98%
1M Performance:
-29.32%
6M Performance:
-15.12%
1Y Performance:
-79.21%
1-Day Range:
$0.351
$0.3797
1-Week Range:
$0.351
$0.4119
52-Week Range:
$0.2375
$1.79
Aethlon Medical Inc Stock (AEMD) Company Profile
Name
Aethlon Medical Inc
Sector
Industry
Phone
619-941-0360
Address
11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO, CA
Compare AEMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AEMD
Aethlon Medical Inc
|
0.3659 | 7.56M | 294.20K | -12.25M | -10.77M | -5.05 |
|
ABT
Abbott Laboratories
|
131.93 | 228.81B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
100.05 | 149.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
377.46 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
88.86 | 113.49B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
72.05 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
Aethlon Medical Inc Stock (AEMD) Latest News
Virtu Financial LLC Buys Shares of 94,173 Aethlon Medical, Inc. (NASDAQ:AEMD) - Defense World
Aethlon Medical (NASDAQ:AEMD) Now Covered by Analysts at StockNews.com - Defense World
Aethlon Medical at Emerging Growth Virtual Conference: Oncology Focus and Financial Strategy - Investing.com
Aethlon Medical (NASDAQ:AEMD) & Nephros (NASDAQ:NEPH) Head to Head Comparison - Defense World
Aethlon Medical (NASDAQ:AEMD) Now Covered by StockNews.com - Defense World
Aethlon Medical issues new warrants, modifies rights By Investing.com - Investing.com Australia
Aethlon Medical issues new warrants, modifies rights - Investing.com
Short Interest in Aethlon Medical, Inc. (NASDAQ:AEMD) Drops By 52.0% - Defense World
Aethlon Medical (NASDAQ:AEMD) Earns Sell Rating from Analysts at StockNews.com - Defense World
Aethlon Medical’s (AEMD) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
Buy Rating for Aethlon Medical Driven by Hemopurifier’s Potential in Organ Transplantation and Projected Growth - TipRanks
Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) Publishes Preclinical Data on the Hemopurifier® in Transplant Immunology Journal - Investorideas.com newswire
Aethlon Medical Publishes Preclinical Data on the Hemopurifier® in Transplant Immunology Journal - Yahoo Finance
Aethlon Medical, Inc. to Host Earnings Call - ACCESS Newswire
Investor Network: Aethlon Medical, Inc. to Host Earnings Call - ACCESS Newswire
HC Wainwright Boosts Earnings Estimates for Aethlon Medical - Defense World
Aethlon Medical (NASDAQ:AEMD) Receives “Buy” Rating from HC Wainwright - Defense World
Aethlon Medical (NASDAQ:AEMD) Raised to Sell at StockNews.com - Defense World
Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Down 21.3% in January - Defense World
Aethlon Medical strengthens oncology trial with protocol updates and cost reductions - MSN
Aethlon Medical IncThe company expects to conduct a capital raise that - Smartkarma
Aethlon’s Earnings Call: Trials and Cost Strategies - TipRanks
Aethlon Medical, Inc. (NASDAQ:AEMD) Q3 2025 Earnings Call Transcript - Insider Monkey
Live Investor Update: Aethlon Medical Unveils Latest Cancer Treatment ProgressCEO Takes Questions - StockTitan
Aethlon Medical operating expenses drop 50% in Q3 2024 - Medical Buyer
Earnings call transcript: Aethlon Medical Q4 2024 sees cost cuts, stock rises - Investing.com Nigeria
Aethlon Medical Reports Q3 Results and Corporate Update - TipRanks
Aethlon Medical Inc. (AEMD) reports earnings - Quartz
Aethlon Medical Achieves Milestone in Oncology Trials - TipRanks
Aethlon's Hemopurifier Cancer Trial Milestone Achieved as Q3 Expenses Drop 50% - StockTitan
Head-To-Head Review: NeuroPace (NASDAQ:NPCE) vs. Aethlon Medical (NASDAQ:AEMD) - Defense World
Critical Analysis: Aethlon Medical (NASDAQ:AEMD) and Becton, Dickinson and Company (NYSE:BDX) - Defense World
Stock Of Aethlon Medical Inc (NASDAQ: AEMD) Dropped By -13.43 Percent Over The Past Month, Is There Room For Downside? – Marketing Sentinel - Marketing Sentinel
Aethlon Medical Inc (AEMD) Stock: A Value Analysis - The News Heater
Aethlon Medical Inc (AEMD) Stock: A Year of Market Movement, Down and Up - The InvestChronicle
Aethlon Medical Q3 Earnings Preview: Cancer & Infectious Disease Pipeline Takes Center Stage - StockTitan
Exosome Diagnostics & Therapeutics Market to Grow by USD 1.01 Billion (2025-2029) with Rising Research in Exosome Therapeutics Boosting the Market, Report on How AI is Driving Market TransformationTechnavio - The Malaysian Reserve
Aethlon Medical (NASDAQ:AEMD) Earns Buy Rating from HC Wainwright - Defense World
Aethlon Medical treats first subject with Hemopurifier device in Australia - Medical Device Network
Medical Therapeutic Stock Aethlon Medical, Inc. (NASDAQ: $AEMD) Gains on Cancer Clinical Trial update - Investorideas.com newswire
Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) Treats First Patient in Australian Hemopurifier® Cancer Trial - Investorideas.com newswire
Aethlon announces treatment of first patient with Hemopurifier in Australia - TipRanks
Revolutionary Blood Filter Could Boost Cancer Immunotherapy Success Rates by 60% - StockTitan
Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Up 201.5% in January - Defense World
Mawson Infrastructure Group Inc. Provides Company Presentation UpdateOn January 27, 2025, Mawson Infrastructure Group Inc. (NASDAQ: MIGI) announced an updated Company Presentation, disclosing information that has been made available to the publ - Defense World
Aethlon Medical Inc Stock (AEMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.82%
1.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):